Replaces Prod. #: ALX-340-051
Endogenous cannabinoid which has been found to occur at concentrations 2 to 9 fold greater than anandamide in peripheral tissue. It acts as a full agonist at the CB2 receptor and an antagonist at the CB1 receptor.
Product Details
| Alternative Name: | O-AEA, O-Arachidonoylethanolamine, Arachidonic acid-(2-aminoethyl)-ester, O-(2-aminoethyl)-5Z,8Z,11Z,14Z-eicosatetraenoic acid ester |
| |
| Formula: | C22H37NO2 |
| |
| MW: | 347.5 |
| |
| CAS: | 443129-35-9 |
| |
| Purity: | ≥95% (TLC) |
| |
| Appearance: | Yellow to brown oil. |
| |
| Solubility: | Soluble in DMSO (45mg/ml), dimethyl formamide (40mg/ml) or ethanol (20mg/ml) |
| |
| Shipping: | Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Use/Stability: | Stable for at least 1 year after receipt when stored, as supplied, at -80°C and under an inert atmosphere. |
| |
| Handling: | Protect from oxygen. Keep under inert gas. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor: A.C. Porter, et al.; J. Pharmacol. Exp. Ther.
301, 1020 (2002),
Abstract;
Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds: T. Sugiura, et al.; J. Biol. Chem.
274, 2794 (1999),
Abstract;
